#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2260	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2470	209.2	0	.	n	.	0	C451T	SNP	451	451	C	838	838	T	249	T,C,G	172,65,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2260	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2470	209.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1571	1571	C	222	C,A	209,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2260	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2470	209.2	0	HET	.	.	.	C207T	.	207	207	C	594	594	C	180	C,T	121,44	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4331	203.5	0	.	n	.	0	T695C	SNP	695	695	T	1418	1418	C	200	C,G,A,T	190,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4331	203.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2694	2694	C	298	C,T,A	284,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4331	203.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2768	2768	A	287	A	269	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4331	203.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3320	3320	C	242	C,T	234,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3610	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4331	203.5	0	HET	.	.	.	A1638G	.	1638	1638	A	2361	2361	A	250	A,G	192,57	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	480	folP	855	855	100.0	folP.l15.c4.ctg.1	2288	50.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1429	1431	AGC	53;56;56	A;G;C	52;55;53	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	918	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3755	58.7	1	SNP	p	S91F	1	.	.	271	273	TTC	849	851	TTC	38;38;38	T;T;C	34;34;38	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	918	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3755	58.7	1	SNP	p	D95G	1	.	.	283	285	GGC	861	863	GGC	41;41;41	G;G;C	41;40;39	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	918	gyrA	2751	2751	99.85	gyrA.l15.c17.ctg.1	3755	58.7	1	SNP	p	G95N	0	.	.	283	285	GGC	861	863	GGC	41;41;41	G;G;C	41;40;39	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	390	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	2075	46.3	1	SNP	p	G45D	0	.	.	133	135	GGC	827	829	GGC	94;95;95	G;G;C	87;88;86	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	290	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1345	39.0	0	.	n	.	0	A197.	DEL	197	197	A	947	947	A	100	A	97	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1100	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3491	76.1	1	SNP	p	D86N	0	.	.	256	258	GAC	865	867	GAC	82;82;84	G;A,C,G;C	63;57,1,1;62	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1100	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3491	76.1	1	SNP	p	R87I	0	.	.	259	261	CGT	868	870	CGT	85;85;85	C;G,C;T,G	75;62,1;70,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1100	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3491	76.1	1	SNP	p	R87W	0	.	.	259	261	CGT	868	870	CGT	85;85;85	C;G,C;T,G	75;62,1;70,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1100	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3491	76.1	1	SNP	p	S87R	1	.	.	259	261	CGT	868	870	CGT	85;85;85	C;G,C;T,G	75;62,1;70,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1100	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3491	76.1	1	SNP	p	S88P	0	.	.	262	264	TCC	871	873	TCC	86;86;87	T,G;C,T;C	71,2;74,3;81	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1024	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3671	67.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	2002	2004	GGC	97;97;98	G,A;G;C,G	79,2;80;79,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2899	46.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1697	1699	GCC	71;71;71	G;C;C	68;68;69	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2899	46.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1700	1702	ATG	71;71;71	A,G;T,G;G,T,A	67,1;67,2;67,1,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2899	46.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1712	1714	ACC	68;69;69	A;C,G;C	63;66,1;67	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2899	46.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1712	1714	ACC	68;69;69	A;C,G;C	63;66,1;67	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2899	46.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2213	2215	ACC	50;50;50	A;C,A;C,T	41;44,1;46,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2899	46.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2267	2269	GCG	56;56;56	G;C;G,C	49;43;48,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2899	46.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2267	2269	GCG	56;56;56	G;C;G,C	49;43;48,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2899	46.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2390	2392	GGT	50;50;50	G;G,T;T,C	48;46,2;46,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2899	46.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2399	2401	AGC	49;49;48	A,G,C;G,T;C,G,A	35,2,1;41,1;34,2,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	582	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2899	46.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2417	2419	CCG	42;38;38	C,G,T;C;G,C	32,2,1;33;33,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	678	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3847	42.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2005	2007	CCG	52;51;51	C,G,T;C;G,C	41,3,1;46;37,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	372	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2561	35.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	888	888	C	28	C	25	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	394	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2460	39.1	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1345	1347	AGA	54;55;56	A;G;A	53;54;55	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	394	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2460	39.1	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1366	1368	GGT	46;46;49	G,A;G,A;T	44,2;44,1;47	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	394	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2460	39.1	1	SNP	p	G120K	1	.	.	358	360	AAG	1075	1077	AAG	56;56;55	A,C;A;G,A	53,2;55;53,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	394	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2460	39.1	1	SNP	p	A121N	1	.	.	361	363	AAC	1078	1080	AAC	56;56;56	A,G;A;C	52,2;53;55	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	394	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2460	39.1	1	SNP	p	N121D	0	.	.	361	363	AAC	1078	1080	AAC	56;56;56	A,G;A;C	52,2;53;55	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	998	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	6050	39.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	88	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1585	13.0	1	SNP	p	V57M	1	.	.	169	171	ATG	840	842	ATG	16;17;17	A;T;G	14;17;17	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
